Technical analysis of Seer, Inc. (SEER): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software.
Price Performance
| 1 month | -5.94% |
| 3 months | +9.20% |
| Year-to-date | +3.83% |
| 1 year | -7.77% |
| 3 years | -20.83% |
52-Week Range
| 52-week High | $2.41 |
| 52-week Low | $1.55 |
| Avg Volume (90d) | 816K |
Technical Indicators
| SMA 50 | $2.06 |
| SMA 200 | $1.89 |
| Beta | 1.60 |
| 30-day Volatility (annualised) | 16.1% |
| Price vs SMA 50 | -7.9% |
| Price vs SMA 200 | +0.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.21 | |
| 2025-11 | $1.92 | -13.1% |
| 2025-12 | $1.83 | -4.7% |
| 2026-01 | $1.82 | -0.5% |
| 2026-02 | $1.72 | -5.5% |
| 2026-03 | $1.68 | -2.3% |
| 2026-04 | $1.95 | +16.1% |
| 2026-05 | $1.87 | -4.1% |
| 2026-06 | $1.66 | -11.2% |
| 2026-07 | $2.22 | +33.7% |
| 2026-08 | $1.96 | -11.7% |
| 2026-09 | $1.90 | -3.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | |
| 2026-09-15 | | |
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | | |
| 2026-09-15 | $0.14 | $2.28B |
| 2026-09-15 | | |
Price
| Price | $1.90 |
| Market Cap | $104M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.46 |
| EV / EBITDA | -1.61 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.10 |
| Current Ratio | 14.74 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -0.55 |